1 January 2019 in Psychiatry Research: Neuroimaging
12 October 2020 in Addiction Biology
8 June 2018 in European Journal of Neuroscience
27 June 2021 in Addiction Biology
23 January 2026 in Translational Psychiatry
Repetitive transcranial magnetic stimulation (rTMS) targeting the orbitofrontal cortex (OFC) has shown promise in treating schizophrenia, yet its immediate and long-term effects on brain dynamics remain unclear. This study investigated the electrophysiological impact of OFC-rTMS by analyzing EEG microstates in patients with schizophrenia and healthy controls. A total of 87 patients were randomized to receive either 20 sessions of 1 Hz OFC-rTMS or sham stimulation, while 51 healthy controls received a single active rTMS session. Resting-state EEG recordings were obtained at baseline, immediately after the first session, and following the full course of treatment. Microstate analysis was performed by clustering EEG topographies into four canonical classes and extracting temporal features. At baseline, patients exhibited elevated microstate C and reduced microstate D compared to controls. A single active session reduced microstate C occurrence in both groups, with no changes observed in the sham group. After 20 sessions, the active rTMS group showed a sustained decrease in microstate C and increased microstate D across multiple metrics. Notably, exploratory subgroup analysis revealed that clinical responders to OFC-rTMS exhibited greater immediate reductions in microstate C following the first session compared to non-responders. These findings suggest that OFC-rTMS induces both immediate and long-term modulation of EEG microstates in schizophrenia, particularly normalizing abnormalities in microstate C. Early EEG responses may serve as potential biomarkers for long-term therapeutic response.
17 June 2026 in Research Square
Suicide is a major global public health challenge, claiming more than 720,000 lives annually. However, existing screening instruments suffer from excessive length and limited dimensional coverage. To address these needs, this study employed a combined cross-sectional and longitudinal design, using multicentre datasets to develop a suicide risk screening tool while simultaneously exploring the core mechanisms underlying suicide risk. From 2020 to 2024, 20,585 participants were included in the study for the preliminary development of the suicide screening tool and the exploration of its underlying mechanisms. Ten machine learning algorithms were compared to identify core items, and receiver operating characteristic curve (ROC), decision curve analysis (DCA), and structural equation modeling (SEM) were used to evaluate the predictive performance, and GLASSO network, Bayesian network and longitudinal network were used to explore potential mechanisms. To ensure the generalizability of the findings, data collected in 2025 from 9,658 participants across 11 institutions in five provinces were included for external validation of the screening tool and associated mechanisms. Elastic net regression was identified as the optimal algorithm, which selected eight core items for the construction of a brief suicide risk screening tool. Despite a 90.36% reduction in item count (75/83), the tool retained strong discriminative ability (AUC = 0.85). Depression emerged as a central predictor of suicide risk, while EPQN2 (“feeling miserable”) increased psychological vulnerability. Most suicide risk factors showed a worsening trend over the three-year follow-up period. External validation demonstrated favorable predictive performance (AUC = 0.88, 0.95). The tool is available at https://ykcnormgram.shinyapps.io/10282/.